Wright Alexis A, Cook Chad, Abbott J Haxby
University of Otago, Dunedin, New Zealand.
Arthritis Rheum. 2009 Jul 15;61(7):925-36. doi: 10.1002/art.24641.
OBJECTIVE: As populations age and the prevalence of hip osteoarthritis (OA) increases, health care providers must manage increasing demands for services. Evidence regarding the progression of hip OA can assist health care practitioners in determining expected patient prognosis and planning care. This systematic review of prospective cohort studies examines prognostic variables in patients with hip OA. METHODS: Articles were selected following a comprehensive search of Medline, EMBase, CINAHL, and Allied and Complementary Medicine from database inception to October 2008 and hand searches of the reference lists of retrieved articles. Inclusion criteria involved 1) estimates of the association between prognostic variables and progression of OA, 2) prospective cohort design, 3) patients diagnosed with hip OA based on established criteria, 4) at least 1 year of followup, and 5) access to the full published text. Two independent reviewers assessed the methodologic quality of each study and the association between prognostic variables and OA progression. RESULTS: Eighteen articles met the inclusion criteria; 17 were considered to be of high quality. Strong evidence of progression was associated with age, joint space width at entry, femoral head migration, femoral osteophytes, bony sclerosis, Kellgren/Lawrence hip grade 3, baseline hip pain, and Lequesne index score > or =10. Strong evidence of no association with progression was associated with acetabular osteophytes. Evidence was weak or inconclusive regarding associations between various other radiographic or clinical variables, molecular biomarkers, or use of nonsteroidal inflammatory drugs. CONCLUSION: Overall, few variables were found to be strongly associated with the progression of hip OA, and a variety of other variables were weakly predictive of outcome.
目的:随着人口老龄化以及髋骨关节炎(OA)患病率的增加,医疗保健提供者必须应对日益增长的服务需求。有关髋OA进展的证据可帮助医疗从业者确定患者的预期预后并规划治疗方案。这项对前瞻性队列研究的系统评价考察了髋OA患者的预后变量。 方法:通过全面检索Medline、EMBase、CINAHL以及综合与补充医学数据库(从建库至2008年10月),并人工检索所获文章的参考文献列表来选取文章。纳入标准包括:1)对预后变量与OA进展之间关联的评估;2)前瞻性队列设计;3)根据既定标准诊断为髋OA的患者;4)至少1年的随访;5)可获取完整发表文本。两名独立评审员评估了每项研究的方法学质量以及预后变量与OA进展之间的关联。 结果:18篇文章符合纳入标准;17篇被认为质量较高。与进展有强关联的证据涉及年龄、入组时的关节间隙宽度、股骨头移位、股骨骨赘、骨质硬化、Kellgren/Lawrence髋关节分级3级、基线髋部疼痛以及Lequesne指数评分≥10。与进展无关联的强证据涉及髋臼骨赘。关于各种其他影像学或临床变量、分子生物标志物或非甾体抗炎药使用之间的关联,证据薄弱或不明确。 结论:总体而言,发现很少有变量与髋OA的进展有强关联,而其他各种变量对结局的预测作用较弱。
Arthritis Rheum. 2009-7-15
Cochrane Database Syst Rev. 2017-5-22
Cochrane Database Syst Rev. 2018-4-17
Cochrane Database Syst Rev. 2025-5-7
Cochrane Database Syst Rev. 2017-1-31
Cochrane Database Syst Rev. 2018-5-5
Cochrane Database Syst Rev. 2018-2-6
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2021-4-19
BMC Musculoskelet Disord. 2024-6-28
Science. 2023-7-21
bioRxiv. 2023-1-3
Indian J Orthop. 2021-8-2
Int J Environ Res Public Health. 2021-5-11
Arthritis Res Ther. 2019-8-23